
In partnership with Novartis, the Health Assessments and Rapid Transformation (HEART) initiative will focus on improving cardiovascular health for residents in three U.S. cities: Nashville, Tennessee; Detroit, Michigan; and San Bernardino, California. These locations were chosen because they have disproportionately higher rates of cardiovascular disease and social vulnerability.
Over the next five years, leaders from Meharry will partner with community stakeholders in each city to co-create, implement, and measure innovative clinical and non-clinical interventions addressing specific drivers of adverse cardiovascular health outcomes. The HEART program will also focus on developing early detection methods and confronting cardiovascular risk factors, such as high blood pressure, high cholesterol, and smoking, through community prevention and education strategies.


